{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:27:46Z","timestamp":1759483666132,"version":"3.44.0"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152250","type":"journal-article","created":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T11:36:42Z","timestamp":1691667402000},"page":"152250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Long-term outcome of status epilepticus-related to systemic lupus erythematosus: An observational study and a systematic review"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0000-9801","authenticated-orcid":false,"given":"Jamal","family":"Mikdashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Allan","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2023.152250_bib0001","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00005792-196807000-00002","article-title":"The neurologic manifestations of systemic lupus erythematosus","volume":"47","author":"Johnson","year":"1968","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0002","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0961203308094362","article-title":"Epilepsy in lupus","volume":"17","author":"Cimaz","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0003","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1212\/01.WNL.0000165959.98370.D5","article-title":"Factors at diagnosis predict subsequent occurrence of seizures in systemic lupus erythematosus","volume":"64","author":"Mikdashi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0004","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/0961203316666961","article-title":"Lupus, antiphospholipid syndrome and epilepsy: an update","volume":"26","author":"Rosati","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0006","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.autrev.2018.01.025","article-title":"Antiphospholipid antibodies in epilepsy: a systematic review and meta-analysis","volume":"17","author":"Islam","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"9","key":"10.1016\/j.semarthrit.2023.152250_bib0007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nrneurol.2013.154","article-title":"Outcome predictors for status epilepticus\u2014what really counts","volume":"9","author":"Sutter","year":"2013","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0008","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/epi.14607","article-title":"Epidemiology of status epilepticus in adults: a population-based study on incidence, causes, and outcomes","volume":"60","author":"Leitinger","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0009","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1001\/jamaneurol.2013.578","article-title":"Predictors of outcome in refractory status epilepticus","volume":"70","author":"Hocker","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/epi.14515","article-title":"Long-term outcomes of status epilepticus: a critical assessment","volume":"59","author":"Sculier","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0011","first-page":"133","article-title":"A case of unusual partial status epilepticus","volume":"2","author":"Sumi","year":"1985","journal-title":"Jst.go.jp (J Japan Epilepsy Society)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0012","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archderm.1987.01660290106026","article-title":"Severe visceral disease in subacute cutaneous lupus erythematosus","volume":"123","author":"Weinstein","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0013","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1177\/155005949002100212","article-title":"Reversible cortical blindness (Anton's syndrome) associated with bilateral occipital EEG abnormalities","volume":"21","author":"Roos","year":"1990","journal-title":"Clin Electroencephalogr"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0014","first-page":"1021","volume":"35","author":"Yoshida","year":"1995"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0015","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1191\/096120398678920523","article-title":"Nervous system lupus mimics limbic encephalitis","volume":"7","author":"Stubgen","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0016","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1007\/s001150170011","article-title":"Reversible bilateral cortical MRI changes as sequelae of status epilepticus","volume":"72","author":"Weidauer","year":"2001","journal-title":"Nervenarzt"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0017","first-page":"986","article-title":"Plasmapheresis: an adjunct therapy in severe progressive neuropsychiatric lupus","volume":"49","author":"Gokhale","year":"2001","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0018","first-page":"1045","volume":"13","author":"Lawson","year":"2003","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0019","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1093\/ndt\/gfg347","article-title":"Reversible posterior leukoencephalopathy in a patient with systemic sclerosis\/systemic lupus erythematosus overlap syndrome","volume":"18","author":"Yong","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0020","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S1059-1311(02)00259-5","article-title":"Complex partial status epilepticus of exratemporal origin in a patient with systemic lupus erythematosus","volume":"12","author":"Fern\u00e1ndez-Torre","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0021","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1191\/0961203303lu381xx","article-title":"Systemic lupus erythematosus in the far north of Queensland","volume":"12","author":"Bossingham","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0022","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1212\/01.WNL.0000144178.32208.4F","article-title":"Epileptic seizures in systemic lupus erythematosus","volume":"63","author":"Appenzeller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0023","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1684\/j.1950-6945.2005.tb00129.x","article-title":"Azuma H. a case of systemic lupus erythematosus with complex partial status epilepticus","volume":"7","author":"Tsugi","year":"2005","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0024","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1345\/aph.1G008","article-title":"Efficacy and tolerability of levetiracetam treatment in epileptic patient with SLE","volume":"39","author":"Siniscalchi","year":"2005","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1385\/NCC:4:2:140","article-title":"Prolonged coma from refractory status epilepticus","volume":"4","author":"Dara","year":"2006","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0026","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2005.12.003","article-title":"The use of levetiracetam in refractory status epilepticus","volume":"15","author":"Patel","year":"2006","journal-title":"Seizure"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0027","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00115-006-2252-2","article-title":"Selektive Immunadsorption bei neurologischen Komplikationen eines systemischen Lupus erythematodes [Selective immunoadsorption in neurologic complications of systemic lupus erythematosus]","volume":"78","author":"Harscher","year":"2007","journal-title":"Nervenarzt"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0028","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1001\/archneurol.2009.273","article-title":"Functional and cognitive outcome in prolonged refractory status epilepticus","volume":"66","author":"Cooper","year":"2009","journal-title":"Arch Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0029","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1528-1167.2008.01782.x","article-title":"Aphasic or amnesic status epilepticus detected on PET but not EEG","volume":"50","author":"Dong","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0030","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jns.2011.11.029","article-title":"Refractory status epilepticus secondary to CNS vasculitis, a role for epilepsy surgery","volume":"315","author":"Atkinson","year":"2012","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0031","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.reumae.2012.07.012","article-title":"Encephalitis and status epilepticus in a patient with systemic lupus erythematosus","volume":"9","author":"Benavente","year":"2013","journal-title":"Reumatol Cl\u00edn (Engl Ed)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0032","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1177\/0961203312474705","article-title":"Periodic lateralized epileptiform discharges (PLEDs) in cerebral lupus correlated with white-matter lesions in brain MRI and reduced cerebral blood flow in SPECT","volume":"22","author":"Aye","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0033","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1007\/s00296-017-3843-x","article-title":"The multifactorial origin of posterior reversible encephalopathy syndrome in cyclophosphamide-treated lupus patients","volume":"37","author":"Zeki\u0107","year":"2017","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0034","article-title":"Severe maternal morbidity associated with systemic lupus erythematosus flare in the second trimester of pregnancy. Case Rep Obstet Gynecol. 2018. 2018:5803479","author":"Blitz","year":"2018","journal-title":"Published online"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0035","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/ccr3.517","article-title":"Seizures associated with Lupus during pregnancy","volume":"4","author":"Aoki","year":"2016","journal-title":"Clin Case Rep"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0036","first-page":"e4783","article-title":"A challenging diagnosis of systemic lupus erythematosus with status epilepticus","volume":"11","author":"Iftikhar","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0037","first-page":"201","article-title":"A patient with systemic lupus erythematosus with acute inflammatory demyelinating polyradiculoneuropathy with progression to encephalopathy and status epilepticus: a case report","volume":"26","author":"de la","year":"2019","journal-title":"Revista Colombiana de Reumatolog\u00eda (Engl Ed)"},{"issue":"2","key":"10.1016\/j.semarthrit.2023.152250_bib0038","doi-asserted-by":"crossref","first-page":"102","DOI":"10.46997\/revecuatneurol30200102","article-title":"Non convulsive status epilepticus due to Systemic Lupus Erythematosus and Anti-phospholipid syndrome","volume":"30","author":"Piana-Castillo","year":"2021","journal-title":"Revista Ecuatoriana de Neurolog\u00eda"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0039","doi-asserted-by":"crossref","first-page":"e04454","DOI":"10.1002\/ccr3.4454","article-title":"Fatal cerebral venous sinus thrombosis as a manifestation of uncontrolled systemic lupus erythematosus in a young African female","volume":"9","author":"Sadiq","year":"2021","journal-title":"Clin Case Rep"},{"issue":"5","key":"10.1016\/j.semarthrit.2023.152250_bib0040","first-page":"e24973","article-title":"Lupus Cerebritis as a Rare Neuropsychiatric Manifestation of Systemic Lupus Erythematosus","volume":"14","author":"Leitao","year":"2022","journal-title":"Cureus"},{"issue":"70S","key":"10.1016\/j.semarthrit.2023.152250_bib0041","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.eplepsyres.2005.11.014","article-title":"ILAE classification of epilepsy syndromes","author":"Engle","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0042","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013report of the ILAE task force on classification of status epilepticus","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0043","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Status epilepticus guideline writing committee Guidelines for the evaluation and management of status epilepticus","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0044","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.neurol.2019.12.010","article-title":"Etiological assessment of status epilepticus","volume":"176","author":"Valton","year":"2020","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0045","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.clineuro.2015.09.010","article-title":"Status epilepticus severity score (STESS): a useful tool to predict outcome of status epilepticus","volume":"139","author":"Goyal","year":"2015","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0046","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/epi.14623","article-title":"Illness severity scoring in status epilepticus\u2014when STESS meets APACHE II, SAPS II, and SOFA","volume":"60","author":"Semmlack","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0047","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.yebeh.2018.02.033","article-title":"Diagnostic value of Status Epilepticus Severity Score for survival conditions of patients with status epilepticus: a PRISMA-compliant systematic review and meta-analysis","volume":"82","author":"Wang","year":"2018","journal-title":"Epilepsy Behav"},{"issue":"5 9","key":"10.1016\/j.semarthrit.2023.152250_bib0048","article-title":"Prognostic scores in status epilepticus\u2014a critical appraisal","author":"Yuan","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0049","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrneurol.2010.178","article-title":"The role of inflammation in epilepsy","volume":"7","author":"Vezzani","year":"2011","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.semarthrit.2023.152250_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1212\/CON.0000000000001079","article-title":"Autoimmune-associated seizures","volume":"28","author":"Gillinder","year":"2022","journal-title":"CONTINUUM Minneap Minn)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0052","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with CNS diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0053","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/BOR.0000000000000655","article-title":"Update on the pathogenesis of central nervous system lupus","volume":"3","author":"Nikolopoulos","year":"2019","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0054","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neulet.2016.12.044","article-title":"Pathophysiology of status epilepticus","volume":"667","author":"Walker","year":"2018","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0055","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/epi4.12242","article-title":"Pharmacological targeting of brain inflammation in epilepsy: therapeutic perspectives from experimental and clinical studies","volume":"3","author":"Ravizza","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0056","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/ana.25655","article-title":"Randomized placebo-controlled trial of intravenous immunoglobulin in autoimmune LGI1\/CASPR2 epilepsy","volume":"87","author":"Dubey","year":"2020","journal-title":"Ann Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0057","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/ana.25374","article-title":"Tocilizumab treatment for new onset refractory status epilepticus","volume":"84","author":"Jun","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0058","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.eplepsyres.2018.03.017","article-title":"Combination of intravenous immunoglobulin and steroid pulse therapy improves outcomes of febrile refractory status epilepticus","volume":"142","author":"Lin","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0059","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2021.107901","article-title":"The risk of cardiac mortality in patients with status epilepticus: a 10-year study using data from the Centers for Disease Control and Prevention (CDC)","volume":"117","author":"Cheng","year":"2021","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0060","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/epi.14515","article-title":"Long-term outcomes of status epilepticus: a critical assessment","volume":"59","author":"Sculier","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0061","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.seizure.2021.02.010","article-title":"Long-term seizure outcome and antiseizure medication use in autoimmune encephalitis","volume":"86","author":"Ilyas-Feldmann","year":"2021","journal-title":"Seizure"},{"issue":"6","key":"10.1016\/j.semarthrit.2023.152250_bib0062","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1212\/CON.0000000000000668","article-title":"Status epilepticus, refractory status epilepticus, and super-refractory status epilepticus","volume":"24","author":"Nelson","year":"2018","journal-title":"Continuum (Minneap Minn)"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0063","doi-asserted-by":"crossref","first-page":"259","DOI":"10.3389\/fneur.2018.00259","article-title":"Management of autoimmune status epilepticus","volume":"9","author":"Kirmani","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0064","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s13311-019-00750-3","article-title":"Autoimmune epilepsy","volume":"16","author":"Husari","year":"2019","journal-title":"Neurotherapeutics"},{"issue":"1093","key":"10.1016\/j.semarthrit.2023.152250_bib0065","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20170869","article-title":"Autoimmune epilepsy: findings on MRI and FDG-PET","volume":"92","author":"Guerin","year":"2019","journal-title":"Br J Radiol"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0066","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019703","article-title":"Tools for assessing risk of reporting biases in studies and syntheses of studies: a systematic review","volume":"8","author":"Page","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0067","doi-asserted-by":"crossref","first-page":"e44534","DOI":"10.1371\/journal.pone.0044534","article-title":"Determinants of recovery from severe posterior reversible encephalopathy syndrome","volume":"7","author":"Legriel","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0068","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102739","article-title":"Posterior reversible encephalopathy syndrome: a neuropsychiatric manifestation of systemic lupus erythematosus","volume":"20","author":"Valdez-L\u00f3pez","year":"2021","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2023.152250_bib0069","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1177\/0961203319856416","article-title":"Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study","volume":"28","author":"Cui","year":"2019","journal-title":"Lupus"},{"issue":"3","key":"10.1016\/j.semarthrit.2023.152250_bib0070","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1136\/jnnp-2014-310145","article-title":"Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study","volume":"87","author":"Merayo-Chalico","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000926?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223000926?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:18Z","timestamp":1758733818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223000926"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":70,"alternative-id":["S0049017223000926"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152250","relation":{},"ISSN":["0049-0172"],"issn-type":[{"type":"print","value":"0049-0172"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcome of status epilepticus-related to systemic lupus erythematosus: An observational study and a systematic review","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152250","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152250"}}